Inflammation and Fatigue in Patients with Cold Agglutinin Disease (CAD): Analysis from the Phase 3 Cardinal Study

被引：8
|
作者：
Weitz, Ilene C.
Ueda, Yasutaka
Shafer, Frank
Su, Jun
Foster, Meredith
Storek, Michael
Patel, Parija
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-140335
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): RESULTS FROM THE PHASE 3 CARDINAL STUDY
    Roeth, A.
    Barcellini, W.
    D'Sa, S.
    Miyakawa, Y.
    Broome, C. M.
    Michel, M.
    Kuter, D. J.
    Jilma, B.
    Tvedt, T. H. Anderson
    Lin, S.
    Jiang, X.
    Reuter, C.
    Hobbs, W.
    Berentsen, S.
    [J]. HAEMATOLOGICA, 2020, 105 : S38 - S38
  • [2] Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Results from the Phase 3 Cardinal Study
    Roth, Alexander
    Barcellini, Wilma
    D'Sa, Shirley
    Miyakawa, Yoshitaka
    Broome, Catherine M.
    Michel, Marc
    Kuter, David J.
    Jilma, Bernd
    Tvedt, Tor Henrik Anderson
    Lin, Stella
    Jiang, Xiaoyu
    Reuter, Caroline
    Hobbs, William
    Berentsen, Sigbjorn
    [J]. BLOOD, 2019, 134
  • [3] Results from the phase 3 Cardinal study part A: Inhibition of complement C1s with Sutimlimab in patients with Cold Agglutinin Disease (CAD)
    Roeth, A.
    Barcellini, W.
    Sa, D. S.
    Miyakawa, Y.
    Broome, C. M.
    Michel, M.
    Kuter, D. J.
    Jilma, B.
    Tvedt, Anderson T. H.
    Lin, S.
    Jiang, X.
    Reuter, C.
    Hobbs, W.
    Berentsen, S.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 177 - 177
  • [4] Concomitant Use of Sutimlimab and COVID-19 Vaccines in Patients with Cold Agglutinin Disease from the Phase 3 Cardinal and Cadenza Studies
    Fattizzo, Bruno
    Roeth, Alexander
    Broome, Catherine M.
    Khan, Umer
    Shafer, Frank
    Cordoba, Matias
    Barcellini, Wilma
    [J]. BLOOD, 2022, 140 : 2839 - 2841
  • [5] INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): INTERIM RESULTS OF THE PHASE 3 CARDINAL STUDY LONG -TERM FOLLOW-UP
    Barcellinia, W.
    Roeth, A.
    D'Sa, S.
    Miyakawa, Y.
    Broome, C. M.
    Michel, M.
    Kuter, D. J.
    Jilma, B.
    Tvedt, T. H. Anderson
    Weitz, I. C.
    Patel, P.
    Jiang, X.
    Reuter, C.
    Su, J.
    Shafer, F.
    Lee, M.
    Hobbsb, W.
    Berentsen, S.
    [J]. HAEMATOLOGICA, 2021, 106 (10) : 107 - 107
  • [6] A complement inhibitor, sutimlimab, to treat the cold agglutinin disease: the CARDINAL study
    Herbreteau, Laura
    Ianotto, Jean-Christophe
    [J]. HEMATOLOGIE, 2021, 27 (03): : 109 - 110
  • [7] Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Interim Results of the Phase 3 Cardinal Study Long-Term Follow-up
    Roth, Alexander
    Barcellini, Wilma
    D'Sa, Shirley
    Miyakawa, Yoshitaka
    Broome, Catherine M.
    Michel, Marc
    Kuter, David J.
    Jilma, Bernd
    Tvedt, Tor Henrik Anderson
    Weitz, Ilene C.
    Patel, Parija
    Jiang, Xiaoyu
    Reuter, Caroline
    Su, Jun
    Shafer, Frank
    Lee, Michelle
    Hobbs, William
    Berentsen, Sigbjorn
    [J]. BLOOD, 2020, 136
  • [8] Interim results of the phase 3 CARDINAL study long-term follow-up: Inhibition of complement C1s with sutimlimab in patients with Cold Agglutinin Disease (CAD)
    Roeth, A.
    Barcellini, W.
    D'Sa, S.
    Miyakawa, Y.
    Broome, C.
    Michel, M.
    Kuter, D.
    Jilma, B.
    Tvedt, T. H. A.
    Weitz, I. C.
    Patel, P.
    Jiang, X.
    Reuter, C.
    Su, J.
    Shafer, F.
    Lee, M.
    Hobbs, W.
    Berentsen, S.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 169 - 170
  • [9] Combined Safety Data for Sutimlimab in Cold Agglutinin Disease: A Post-Hoc Analysis of the Phase 3 Cardinal and Cadenza Studies
    Broome, Catherine M.
    Barcellini, Wilma
    Ueda, Yasutaka
    Khan, Umer
    Patel, Reena
    Wardecki, Marek
    Kralova, Katarina
    Srivastava, Shruti
    Roeth, Alexander
    [J]. BLOOD, 2023, 142
  • [10] Efficacy of Sutimlimab in Improving FACIT-Fatigue Scores in Patients with Cold Agglutinin Disease: A Post-Hoc Analysis of the Phase 3 Cadenza (Part A) Study
    Roeth, Alexander
    Weitz, Ilene
    Ueda, Yasutaka
    Bozzi, Sylvie
    Patel, Reena
    Karaouni, Alia
    Yoo, Ronnie
    Cella, David
    Wang, Jennifer
    [J]. BLOOD, 2023, 142
12345